Themes / Cluster
Inactive · established relationshipLatest completed snapshot · Oct 7 · 18:22 ET

MARKET-DISCOVERED GROUP

Biotechnology

THE TRADER READRecurring relationship, inactive in the latest snapshot

3 of 5 measured session-normalized paths align to the downside across 3.2 effective names. CGEM, STOK, TRVI are also moving with filing-linked members. Capital-flow agreement is 45%, so the basket is not yet clean. No verified headline preceded the measured move.

Price breadth3 up · 2 down-0.4% session-normalized median path
Capital-flow alignment45%Price breadth is not yet confirmed by flow
Activity nowCalmActivity score 9/100 · lift 0.8×
Evidence depth3 support daysLow sample—context, not a validated playbook
EVIDENCE CLOCK

What happened, in timestamp order

4 timed events · 15:30–15:55 ET
TIMING READNo verified timestamped headline was found within 24 hours of the first measured price move in the available common-bar window. The move currently reads as market-led or unexplained.
  1. 5-minute inferenceFDMT registered the first material downside path

    -0.55% session path at the threshold · FDMT

  2. 5-minute inferenceKURA registered a material upside path

    +0.86% session path at the threshold · KURA

  3. 5-minute inferenceCLDX registered a material downside path

    -0.88% session path at the threshold · CLDX

  4. 5-minute inferenceKYTX registered a material upside path

    +2.19% session path at the threshold · KYTX

2 earlier filing context receipts

WED, MAR 25KYTX filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

WED, AUG 5CLDX filing documented shared operating contextproduct pipeline / R&D affecting expense · date precision only

Headline times and retained activity confirmations are point-in-time evidence. Price order is inferred from aligned 5-minute bars. Filing evidence has date precision only and is context, not an intraday catalyst claim.
THEME CONSTRUCTION

Broad move or one-stock disguise?

Session-normalized 5m paths

Observed movement is balanced across 3.2 effective names. CLDX represents 39.3% of absolute path energy; 3 of 5 members align with the down relative path.

ConstructionBalanced39.3% from the largest path
Effective names3.2 / 5Movement diversity after concentration
Direction breadth3/5 aligneddownside relative path · 2 counter-moving
Largest moverCLDX 39.3%77.3% from the top two paths
CLDX39.3%Dominant mover · path -2.23% · basket -0.45pp
KURA38.0%Dominant mover · path +2.15% · basket +0.43pp
FDMT9.8%Aligned contributor · path -0.55% · basket -0.11pp
IMCR7.2%Aligned contributor · path -0.41% · basket -0.08pp
KYTX5.7%Counter-move · path +0.33% · basket +0.07pp
Top six names by movement share are shown. Movement share measures absolute 5-minute path energy; signed basket contribution is equal-weight. Neither is a portfolio weight or causal attribution.

01 · WHAT IS HAPPENING

The move, the flow and who is driving it

Price breadth, unusual activity and signed capital flow are separate observations
HOW THE PRICE MOVE SPREAD

Observed session sequence

5-minute bars · inferred
  1. FDMT moved lower firstFirst member to clear the material path threshold · path -0.55%
  2. KURA registered a material higher path20m after the first price move · path +0.86%
  3. CLDX registered a material lower path1250m after the first price move · path -0.88%
  4. KYTX registered a material higher path1250m after the first price move · path +2.19%
  5. IMCR registered a material lower path1325m after the first price move · path -0.78%

Sequence inferred from aligned 5-minute price paths; it is not a causal ordering.

RELATIVE CO-MOVEMENT

How the members are behaving together

Session-normalized
Oct 6 · 15:30 ETMove visible 12:25 ETOct 7 · 15:55 ET
Group median -0.41%Strongest relative path KURAWeakest relative path CLDX

Observed member paths normalized to the session. The dashed marker shows when the median move first cleared a material threshold; shading marks the latest 20% of the observed window.

02 · WHY IT MATTERS

Why now and where the move could travel

Context and lead/lag links are evidence, not proof of causation or a forecast
WHY NOW

Verified recent context

0 items

No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.

WHY THIS GROUP EXISTS

Shared filing context

5/5 members covered

Moderate filing support: the strongest shared 10-Q/K outlook is operating setup (near-term outlook) across CLDX, FDMT, IMCR, KURA, KYTX.

product pipeline / R&D affecting expense

“The change in our net operating assets and liabilities was primarily due to an increase in other accrued expenses and current liabilities of $10.9 million, primarily due to an increase in accrued CRO and CMO research and development expenses, an increase in accrued compensation of $2.1 million, and an increase in accounts payable of $0.7 million, partially offset by a decrease in operating lease liabilities of $2.4 million, an increase in other non-current assets of $2.0 million, and an increase in prepaid expenses and other current assets of $1.5 million.”

KYTX 10-K · 2026-03-26
product pipeline / R&D affecting revenue

“As a result, we might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay or limit our commercial launch of the product, possibly for lengthy time periods, which could negatively impact the revenue we generate from the sale of the product in that particular country.”

KYTX 10-Q · 2025-11-12
restructuring affecting expense

“Personnel-related expenses increased by $0.4 million, or 5%, for the three months ended September 30, 2025, compared to the same period a year ago, primarily due to higher severance and other employee costs in our research and development organization.”

KYTX 10-Q · 2025-11-12
CONFIRMATION NETWORK

Outsiders and cross-asset links

4 outsiders confirming

No qualified cross-asset lead/lag link is available for this group.

Filing-linked outsiders test whether the move is spreading beyond the established cohort.

CGEMMoving with group

KURA · text peer

STOKMoving with group

FDMT · text peer

TRVIMoving with group

FDMT · text peer

KODMoving with group

CLDX · text peer

03 · WHO IS IN IT

Member participation

Unusual activity and daily price direction are shown separately
KURAKYTXIMCRCLDXFDMT

5/5 active3 rising · 2 falling

MemberUnusual activityToday's moveRead now
KURAKura Oncology, Inc.
Elevated · 100/100
+1.3%
Dominant path moverActive in 0% of observed group sessions
KYTXKyverna Therapeutics, Inc.
Most unusual · 86/100
+0.2%
Counter-move / dispersionActive in 0% of observed group sessions
IMCRImmunocore Holdings plc
Elevated · 78/100
-0.8%
Aligned price + flowActive in 0% of observed group sessions
CLDXCelldex Therapeutics, Inc.
Elevated · 40/100
-1.8%
Dominant path moverActive in 0% of observed group sessions
FDMT4D Molecular Therapeutics, Inc.
Elevated · 40/100
+0.3%
Aligned price + flowActive in 0% of observed group sessions
View exact member values
TICKERCompanyRole nowTodayObserved historyTrader interpretation
KURAKura Oncology, Inc.Participating+1.3%0% of 0 sessionsPrice participation with distributing signed flow.
KYTXKyverna Therapeutics, Inc.Most unusual+0.2%0% of 0 sessionsMost unusual activity in this snapshot; performance direction may differ.
IMCRImmunocore Holdings plcParticipating-0.8%0% of 0 sessionsPrice participation with distributing signed flow.
CLDXCelldex Therapeutics, Inc.Participating-1.8%0% of 0 sessionsPrice participation with distributing signed flow.
FDMT4D Molecular Therapeutics, Inc.Participating+0.3%0% of 0 sessionsPrice participation with distributing signed flow.

04 · HAS THIS HAPPENED BEFORE

Identity history versus measured outcomes

Structural recurrence is not the same as a validated trading outcome
POINT-IN-TIME LIVE OUTCOMES

Live outcome ledger collecting

0/0 events completed

No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.

Only point-in-time live watcher observations and conservative same-day EOD observations are included. Later backfills and replay runs are excluded.
Low structural sample

Only 0 completed episodes across 0 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.

Structural support3 daysHow often the cohort identity was observed
Completed episodes0Separate periods of broad group activity
Active sessions0Completed session observations, not trades
2026-10-075 names in the durable cohort
2026-10-063 names in the durable cohort
2026-10-052 names in the durable cohort
MEMBER CONSISTENCY IN OBSERVED ACTIVE SESSIONS
CLDX0% · 0 episodes
FDMT0% · 0 episodes
IMCR0% · 0 episodes
KURA0% · 0 episodes
KYTX0% · 0 episodes